Martec/Egis Pharmaceuticals partnership
Executive Summary
Martec agreement with Budapest, Hungary-based firm provides the U.S. company with all pharmaceutical compounds developed by Egis over the next 13 years. Martec will have the exclusive right to market these compounds in the U.S., Canada and Mexico. Martec also will aid Egis in establishing a new R&D facility. Egis generates annual revenues of $ 175 mil., according to Martec.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.